Modeling Suggests SARS-CoV-2 Rebound after Nirmatrelvir-Ritonavir Treatment is Driven by Target Cell Preservation Coupled with Incomplete Viral Clearance
JOURNAL OF VIROLOGY(2025)
Key words
SARS-CoV-2,viral rebound,nirmatrelvir-ritonavir,antiviral therapy,target cell preservation,mathematical model,viral dynamics,adaptive immune response,incomplete viral clearance,treatment timing
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined